Skin Toxicity Due to Mercaptopurine in Maintenance Therapy Among Children With Acute Lymphoblastic Leukemia

被引：1

作者：

Higgerson, Kayeleigh ^{[1
,2
]}

Flatt, Terrie ^{[1
]}

机构：

[1] Childrens Mercy Hosp, BMT, Dept Pediat Hematol Oncol, Kansas City, MO USA

[2] Childrens Mercy Hosp, 2401 Gillham Rd, Kansas City, MO 64108 USA

来源：

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | 2023年 / 45卷 / 04期

关键词：

mercaptopurine; acute lymphoblastic leukemia; skin toxicity; allopurinol; thiopurine metabolites; 6MMPN; ALLOPURINOL; METABOLITES; 6-MERCAPTOPURINE;

D O I：

10.1097/MPH.0000000000002667

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Mercaptopurine is a crucial component in the treatment of acute lymphoblastic leukemia. It is associated with toxicities that can delay treatment. Mercaptopurine is metabolized into 6-thioguanine nucleotides and 6-methylomercaptopurine nucleotides (6MMPN). Accumulation of 6MMPN has previously been associated with hepatotoxicity, pancreatitis, and hypoglycemia. However, skin toxicity has rarely been reported. We report 5 cases of elevated 6MMPN levels associated with cutaneous manifestations.

引用

页码：E514 / E517

页数：4

共 50 条

[41] Thiopurine methyltransferase polymorphisms and mercaptopurine tolerance in Turkish children with acute lymphoblastic leukemia
Albayrak, Meryem
Konyssova, Uljan
Kaya, Zuhre
Gursel, Turkiz
Guntekin, Sezen
Percin, E. Ferda
Kocak, Ulker
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (05) : 1155 - 1159
[42] Thiopurine methyltransferase polymorphisms and mercaptopurine tolerance in Turkish children with acute lymphoblastic leukemia
Meryem Albayrak
Uljan Konyssova
Zuhre Kaya
Turkiz Gursel
Sezen Guntekin
E. Ferda Percin
Ulker Kocak
Cancer Chemotherapy and Pharmacology, 2011, 68 : 1155 - 1159
[43] Acquired factor V deficiency in the setting of mercaptopurine therapy for acute lymphoblastic leukemia
Uminski, Kelsey
Khalife, Roy
Fulcher, Jill
Duffett, Lisa
Wang, Tzu-Fei
Tinmouth, Alan
ANNALS OF HEMATOLOGY, 2022, 101 (05) : 1137 - 1139
[44] The role of functional polymorphisms in folate metabolism on 6-mercaptopurine-mediated hematological toxicity in children with acute lymphoblastic leukemia
Patchva, Dorababu
Linga, Vijay Gandhi
Digumarti, Raghunadharao
CANCER RESEARCH, 2012, 72
[45] Acquired factor V deficiency in the setting of mercaptopurine therapy for acute lymphoblastic leukemia
Kelsey Uminski
Roy Khalife
Jill Fulcher
Lisa Duffett
Tzu-Fei Wang
Alan Tinmouth
Annals of Hematology, 2022, 101 : 1137 - 1139
[46] Improved therapy for children with acute lymphoblastic leukemia
Komada, Y
Sakurai, M
BIOMEDICINE & PHARMACOTHERAPY, 1996, 50 (3-4) : 132 - 139
[47] Pharmacogenetic Predictors of Treatment-Related Toxicity Among Children With Acute Lymphoblastic Leukemia
Rochelle R. Maxwell
Peter D. Cole
Current Hematologic Malignancy Reports, 2017, 12 : 176 - 186
[48] Pharmacogenetic Predictors of Treatment-Related Toxicity Among Children With Acute Lymphoblastic Leukemia
Maxwell, Rochelle R.
Cole, Peter D.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2017, 12 (03) : 176 - 186
[49] Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites
Toksvang, Linea Natalie
De Pietri, Silvia
Nielsen, Stine N.
Nersting, Jacob
Albertsen, Birgitte K.
Wehner, Peder S.
Rosthoj, Steen
Lahteenmaki, Paeivi M.
Nilsson, Daniel
Nystad, Tove A.
Grell, Kathrine
Frandsen, Thomas L.
Schmiegelow, Kjeld
PEDIATRIC BLOOD & CANCER, 2017, 64 (09)
[50] Adherence to Oral Medications During Maintenance Therapy Among Children and Adolescents With Acute Lymphoblastic Leukemia: A Medication Refill Analysis
Wu, Yelena P.
Stenehjem, David D.
Linder, Lauri A.
Yu, Bin
Parsons, Bridget Grahmann
Mooney, Ryan
Fluchel, Mark N.
JOURNAL OF PEDIATRIC ONCOLOGY NURSING, 2018, 35 (02) : 86 - 93

← 1 2 3 4 5 →